NJ State Employees Deferred Compensation Plan - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$765,776
-57.5%
91,600
+26.2%
0.12%
-55.4%
Q2 2023$1,803,384
+65.2%
72,6000.0%0.26%
+53.8%
Q1 2023$1,091,904
+27.1%
72,6000.0%0.17%
+21.6%
Q4 2022$858,858
+99.7%
72,6000.0%0.14%
+87.8%
Q3 2022$430,000
+273.9%
72,600
+168.9%
0.07%
+289.5%
Q2 2022$115,000
-55.3%
27,0000.0%0.02%
-45.7%
Q1 2022$257,000
-49.9%
27,0000.0%0.04%
-46.2%
Q4 2021$513,000
-42.9%
27,0000.0%0.06%
-46.7%
Q3 2021$899,000
-14.1%
27,0000.0%0.12%
-12.2%
Q2 2021$1,047,000
-19.5%
27,0000.0%0.14%
-24.9%
Q1 2021$1,301,000
-7.4%
27,0000.0%0.18%
-14.7%
Q4 2020$1,405,000
+94.3%
27,0000.0%0.22%
+66.9%
Q3 2020$723,000
+37.5%
27,0000.0%0.13%
+31.3%
Q2 2020$526,000
+97.7%
27,0000.0%0.10%
+62.3%
Q1 2020$266,000
-11.3%
27,0000.0%0.06%
+19.6%
Q4 2019$300,000
+97.4%
27,0000.0%0.05%
+82.1%
Q3 2019$152,00027,0000.03%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders